---

$2.12

+0.1150 ( +5.75% ) 466.5K

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.

Analyst Insights

---

You need to login to view this content.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-12-13	Buy	53418.00	Guerrero Ramiro
2024-12-13	Buy	25000.00	Smith Stan
2024-11-04	Buy	100000.00	Smith Stan
2024-11-04	Buy	22133.00	Luput Cristian
2024-11-04	Buy	22133.00	CHAOUKI STEVEN M
2024-11-04	Buy	88534.00	Guerrero Ramiro
2024-07-02	Sale	-5728.00	Luput Cristian
2024-07-02	Sale	-7160.00	Smith Stan
2024-07-02	Sale	-5728.00	CHAOUKI STEVEN M
2024-07-02	Sale	-8592.00	Louie Ngar Yee

Reset

Symbol	Issuer Name	Market Value ↓	Share Quantity
No records found.